ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Pushing Myc inhibition closer to the clinic

20/03/2019|Comments Off on Pushing Myc inhibition closer to the clinic

Results from the phase 1/2 BEECH study: the promise of ctDNA for the ‘real time’ prediction of response to therapy

20/03/2019|Comments Off on Results from the phase 1/2 BEECH study: the promise of ctDNA for the ‘real time’ prediction of response to therapy

2nd VHIO-IDIBELL-ICO Patient Awareness Symposium: When Prostate Cancer Comes Back, 12 April 2019

18/03/2019|Comments Off on 2nd VHIO-IDIBELL-ICO Patient Awareness Symposium: When Prostate Cancer Comes Back, 12 April 2019

New biomarker revealed as predictor of response to CDK4/6 inhibitors: latest findings reported in Molecular Cancer Therapeutics

11/03/2019|Comments Off on New biomarker revealed as predictor of response to CDK4/6 inhibitors: latest findings reported in Molecular Cancer Therapeutics

See all news
BROWSE OUR PIs
Launch our Scientific Report 2017

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

Follow us:

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
BBVA FOUNDATION’s IMMUNOTHERAPY
& IMMUNOLOGY PROGRAM (CAIMI)
OBRA SOCIAL “LA CAIXA”
INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

FEATURED EVENT 2019
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS